Skip to main content
Premium Trial:

Request an Annual Quote

Not Involved

An initiative to train pharmaceutical manufacturers in Latin America, Asia, and Africa to make SARS-CoV-2 vaccines has languished, the Los Angeles Times reports.

It adds Costa Rican President Carlos Alvarado Quesada came up with the idea for the World Health Organization's COVID-19 Technology Access Pool in the early days of the pandemic as a means of enabling quick, global vaccine production. But the LA Times says the effort was largely stymied by vaccine developers that wanted to protect trade secrets surrounding their mRNA vaccine technology and did not participate in the effort.

"The sole reason these vaccines aren't being produced widely by other makers is because these companies don't want to give up their monopoly," Matthew Kavanagh from Georgetown's O'Neill Institute tells the LA Times.

The LA Times adds, though, that there is increasing pressure on the Biden Administration in the US to boost global vaccine production, possibly through a temporary waiver of intellectual property rights. The paper also notes that as the US government funded mRNA research and holds a key patent, it could insist the companies cooperate.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.